Header Logo

Connection

Dusan Stefoski to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Dusan Stefoski has written about Alemtuzumab.
Dusan Stefoski
Connection Strength
0.021
Alemtuzumab
  1. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol. 2009 Mar; 8(3):244-53.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.